Shares of Johnson & Johnson (NYS:JNJ) slipped 1.86% to $175.50 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 4.04% to 3,923.68 and Dow Jones Industrial Average (DOW:DJIA) falling 3.57% to 31,490.07. The stock's fall snapped a two-day winning streak. Johnson & Johnson closed $11.19 below its 52-week high ($186.69), which the company reached on April 25th.
The stock underperformed when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. (OTC:RHHVF) fell 0.01% to $322.59, Merck & Co. Inc. (NYS:MRK) fell 0.97% to $92.10, and Pfizer Inc. (NYS:PFE) fell 1.83% to $50.40. Trading volume (8.5 M) eclipsed its 50-day average volume of 7.7 M.